Abstract: A pallet structure having a deck having an upper surface that can hold or bear a load, a first runner core below the deck, and a shell of sheet material that can cover a portion of a surface of the first runner core or deck, wherein the shell comprises a material that provides a higher impact resistance than the material comprising the first runner core or deck covered by the shell.

Abstract: A panel structure having a low-density core that can withstanding loads normal to a first primary surface, and a first facing of high-density sheet material that can extend along the first primary surface. The high-density sheet material can be laminated on the core such that the laminated core and facing cooperatively resist bending loads and loads along the primary surface. The first facing can extend from the first primary surface on a side of the core along a secondary surface, which can be non-parallel to the first primary surface. The first facing can bend along a score line between the first primary surface and the secondary surface.

Abstract: An endoscope including a control section; and a shaft extending from the control section. The shaft includes a frame having a one-piece tube, The tube includes at least one slot into the tube to form spaced sections on opposite sides of the slot. A first one of the sections includes at least one projection which extends into at least one pocket of a second one of the sections such that the projection and pocket form an over-travel limiter to limit relative motion of the first and second sections relative to each other in at least one direction.

Abstract: The Direction of Cut Indicator is intended to be used by groundskeepers mowing the turf. It displays the direction the turf is to be cut on the day it is being cut.

Abstract: An endoscope including a control section; and a shaft extending from the control section. The shaft includes a frame including a one-piece tube. The tube includes a plurality of slots into the tube along at least one length of the tube to form spaced sections on opposite sides of each slot. A first one of the sections comprises a projection which extends into a pocket of a second one of the sections such that the projection and pocket form an over-travel limiter to limit relative motion of the first and second sections relative to each other in at least one direction.

Abstract: The system of the present invention facilitates the collection, processing, optimization and communication of data. Project data is accessed through an architecture, comprising an access layer, with programs for retrieving, processing and communicating data from a database, and a Customer User Interface (CUI) presentation layer. The CUI provides individual users with interaction throughout the project life-cycle, for example, for recording and processing information, completing project tasks, producing and managing documents, managing changes, issues and risks and producing reports and business intelligence, including individual project and projects portfolio status indicators.

Abstract: A parsing method for a graphical user interface interaction process, the method comprising defining a control symbol for direction to a text based input field and defining when the control symbol is input to an input box of a graphical user interface that a processor is directed to the text based input field associated with the control symbol.

Abstract: The present invention provides matrix-forming, sustained-release pharmaceutical formulations comprising four primary components: i) an effective amount of at least one drug substance; ii) at least one pharmaceutically acceptable, water-swellable, pH independent polymer; iii) at least one pharmaceutically-acceptable, anionic, pH dependent polymer; and (iv) a pharmaceutically-acceptable polymer selected from the group consisting of a) at least one pharmaceutically-acceptable cationic polymer; and b) at least one pharmaceutically acceptable hydrocolloid. The present formulations can be used with compounds having a wide range of solubilities as well as compounds characterized as having hydrophobic or hydrophilic characteristics.

Abstract: The present invention provides matrix-forming, sustained-release pharmaceutical formulations comprising four primary components: i) an effective amount of at least one drug substance; ii) at least one pharmaceutically acceptable, water-swellable, pH independent polymer; iii) at least one pharmaceutically-acceptable, anionic, pH dependent polymer; and (iv) a pharmaceutically-acceptable polymer selected from the group consisting of a) at least one pharmaceutically-acceptable cationic polymer; and b) at least one pharmaceutically acceptable hydrocolloid. The present formulations can be used with compounds having a wide range of solubilities as well as compounds characterized as having hydrophobic or hydrophilic characteristics.

Abstract: A grooved electrode adapted for interfacing cellular matter is provided. The grooved electrode includes grooves adapted for electrically interfacing the grooved electrode with cellular matter growing along the body of the grooved electrode. Further, the grooved electrode includes a wireless transponder adapted to electrically interface with cellular matter and to relay such interactions via RF signals. The RF signals received by the wireless transponder are modulated in response to electrical signals generated by the cellular matter, which are detected by the transponder. The grooved electrode may be implanted within peripheral nerves for treating various neurological conditions, which may include nerve rehabilitation and prosthetic actuation, severe pain, obstructive sleep apnea and so forth.

Abstract: Process for reducing cracking in superalloy metal components by selectively growing large single grains during the casting operation at a region where fusion welding will be required.

Abstract: A system for interfacing cellular matter with a machine comprising a transponder implantable in cellular matter and configured to detect a first signal. The system also includes a receiver external to the cellular matter and configured to receive a second signal in response to the transponder detection of the first signal. A transmitter is also included in the system to transmit a third signal to a machine in response to the receiver receipt of the second signal.

Abstract: A drain fitting comprising a cage having a plurality of apertures extending through the cage; a conduit having an inlet and an outlet, the conduit extending at least partially through the cage; and a base cap attached to the cage, the outlet located within the base cap wherein the conduit includes an internal surface that extends from the inlet to the outlet, the internal surface increasing the velocity of the water substantially the length of the internal surface as the water passes from the inlet to the outlet.

Abstract: A method for producing borohydride by causing current to flow in an electrolytic cell between an anode and a cathode, wherein a solution of trialkoxyborohydride is in contact with the cathode.

Abstract: A grooved electrode adapted for interfacing cellular matter is provided. The grooved electrode includes grooves adapted for electrically interfacing the grooved electrode with cellular matter growing along the body of the grooved electrode. Further, the grooved electrode includes a wireless transponder adapted to electrically interface with cellular matter and to relay such interactions via RF signals. The RF signals received by the wireless transponder are modulated in response to electrical signals generated by the cellular matter, which are detected by the transponder. The grooved electrode may be implanted within peripheral nerves for treating various neurological conditions, which may include nerve rehabilitation and prosthetic actuation, severe pain, obstructive sleep apnea and so forth.

Abstract: A method and apparatus are disclosed in a data processing system for dynamically selecting one of multiple different I/O firmware images for booting a particular I/O controller that is included in the data processing system. Multiple different I/O firmware images are provided. A configuration of the I/O controller is determined. One of the I/O firmware images is identified that supports the configuration of the particular I/O controller. The identified I/O firmware image is then dynamically selected for booting said I/O controller.

Abstract: Methods and devices for hypodermic implanting micro-transponders into a body. The method includes preassembling an array of micro-transponders into a cannula which is configured for tissue penetration and injection.

Abstract: A grooved electrode adapted for interfacing cellular matter is provided. The grooved electrode includes grooves adapted for electrically interfacing the grooved electrode with cellular matter growing along the body of the grooved electrode. Further, the grooved electrode includes a wireless transponder adapted to electrically interface with cellular matter and to relay such interactions via RF signals. The RF signals received by the wireless transponder are modulated in response to electrical signals generated by the cellular matter, which are detected by the transponder. The grooved electrode may be implanted within peripheral nerves for treating various neurological conditions, which may include nerve rehabilitation and prosthetic actuation, severe pain, obstructive sleep apnea and so forth.

Abstract: Systems and methods are disclosed for managing customers who are either entering into or presently in a significant business growth cycle. In one embodiment, a sales manager and an account manager may analyze a customer profile. The customer profile may be based on data collected from the respective customer. The account manager may then select an AGF customer based on at least the analysis, and identify at least one business objective of the AGF customer. The account manager may further develop an AGF growth plan including a solution to help the AGF customer achieve the at least one business objective. The account manager may deliver the solution to the AGF customer according to the AGF growth plan and determine a value of the delivered solution in helping the AGF customer achieve the at least one business objective.

Abstract: Modified release dosage forms for daily oral dosing to a human patient for providing relief from pain are provided. The modified release dosage form comprises an immediate release component and a sustained release component, wherein the immediate release component and the sustained release component collectively contain a therapeutically effective amount of acetaminophen and an optional therapeutically effective amount of active pharmaceutical ingredient such as an opioid or opioid-like analgesic. In one embodiment, the opioid or opioid-like analgesic is propoxyphene napsylate or propoxyphene HCl salt.